Search This Blog

Wednesday, November 6, 2019

Unity Biotechnology reports Q3 results

Unity Biotechnology (NASDAQ:UBX): Q3 GAAP EPS of -$0.51.
Cash, cash equivalents and investments of $120.3M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)